Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Alkem Laboratories
Alkem Laboratories
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
Novo Holdings completes acquisition of Catalent
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
You need to be a subscriber to read this article.
Click here
to find out more.
Industrial data mastery: navigating the 2025 landscape
As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack
Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging
Fluidic Sciences relaunches Microfluidic Diffusional Sizing technology to refine protein-protein interaction analysis
The Microfluidic Diffusional Sizing (MDS) technology allows scientists better options when characterising a protein's biophysical properties
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Manufacturing
Alkem subsidiary opens continuous biologics manufacturing facility
Indian CDMO Enzene Biosciences, built the new facility in half the time it takes for a conventional biologics manufacturing plant
Manufacturing
Alkem API plant in Gujarat gains EIR approval from US FDA
Indian firm started strengthening its US presence in 2010
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Regulatory
News in Brief
Regulatory
India outpaces global companies launches
Subscribe now